This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous.Find sources: "Masakatsu Shibasaki" – news · newspapers · books · scholar · JSTOR (October 2017) (Learn how and when to remove this message) This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (October 2017) (Learn how and when to remove this message) (Learn how and when to remove this message)
Masakatsu Shibasaki
Born(1947-01-25)25 January 1947
Saitama, Japan
NationalityJapanese
Alma materUniversity of Tokyo
Known forShibasaki catalysts, Binol, enantioselective heterobimetallic catalysis
AwardsAmerican Chemical Society Award for Creative Work in Synthetic Organic Chemistry (2008)
Scientific career
FieldsChemistry
InstitutionsMicrobial Chemistry Research Center
Doctoral advisorShun’ichi Yamada

Masakatsu Shibasaki (柴崎 正勝, Shibasaki Masakatsu, born 25 January 1947) is a Japanese chemist. In 1974 he earned his doctorate in chemistry, in the group of Shun’ichi Yamada. He did a post doc with Elias J. Corey at Harvard. He returned to Japan and became a professor in 1977 at Teikyō University and moved to Hokkaidō University in 1986. 1983–1986 Shibasaki was a research group leader at the Sagami chemical research center. From 1991 until 2010 he served as professor at Tokyo University. Since 2010 he is representative director of Microbial Chemistry Research Foundation (Chemistry), Tokyo. He is perhaps best known for developing a range of binol based heterobimetallic catalysts, which now bear his name.

Selected publications

[edit]

His research interests are focussed on the development of new synthetic methods, the design of biologically significant compounds and synthetic studies of such compounds.

[edit]